Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Diagnostic and Predictive Utility of Serum Biomarkers and Magnetic Resonance Imaging Predictors for Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis
EF 2022-23
Résumé
Cognitive impairment (CI) is a clinical manifestation of Multiple Sclerosis (MS) that has received little attention compared to its other symptoms. There has been a growing interest in being able to detect current and future CI by simply measuring specific markers in a patient’s serum (the liquid part of the blood). These are what we call serum biomarkers and they include specific proteins, like the Neurofilament Light chain (NfL) and Glial Fibrillary Acid Protein (GFAP). The purpose of our study was to explore whether serum NfL or GFAP could provide any additional information on current and/or future CI compared to existing techniques, like magnetic resonance imaging (MRI). We will study this in 50 Relapsing-Remitting Multiple Sclerosis patients, a specific type of MS population that no studies have answered this question in. Several types of data will be collected from these participants over 24 months, which include serum NfL and GFAP levels, various MRI imaging markers, and cognitive assessments. After collecting this data, we will compare the relationship between the independent variable, baseline predictor variables (sNfL, sGFAP or MRI predictors), and several dependent variables, like baseline cognitive performance (representative of current CI), change in cognitive performance (representative of cognitive decline) and the rate of change in cognitive performance. We hypothesize that the MRI markers will be more strongly correlated with current CI, whereas serum biomarkers will be more strongly correlated with future and a faster rate of cognitive decline. The findings of this study will have crucial implications for knowing the strengths and limitations of each predictor variable, so that future studies could use this to design effective combinatorial strategies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486263
Name
Sahoo Saswat
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Diagnostic and Predictive Utility of Serum Biomarkers and Magnetic Resonance Imaging Predictors for Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Cognitive Impairment; Glial Fibrillary Acidic Protein; Humans; Imaging Biomarkers; Magnetic Resonance Imaging; Multiple Sclerosis; Neurofilament Light Chain; Relapsing-Remitting Multiple Sclerosis; Serum Biomarkers
Abstract
Cognitive impairment (CI) is a clinical manifestation of Multiple Sclerosis (MS) that has received little attention compared to its other symptoms. There has been a growing interest in being able to detect current and future CI by simply measuring specific markers in a patient’s serum (the liquid part of the blood). These are what we call serum biomarkers and they include specific proteins, like the Neurofilament Light chain (NfL) and Glial Fibrillary Acid Protein (GFAP). The purpose of our study was to explore whether serum NfL or GFAP could provide any additional information on current and/or future CI compared to existing techniques, like magnetic resonance imaging (MRI). We will study this in 50 Relapsing-Remitting Multiple Sclerosis patients, a specific type of MS population that no studies have answered this question in. Several types of data will be collected from these participants over 24 months, which include serum NfL and GFAP levels, various MRI imaging markers, and cognitive assessments. After collecting this data, we will compare the relationship between the independent variable, baseline predictor variables (sNfL, sGFAP or MRI predictors), and several dependent variables, like baseline cognitive performance (representative of current CI), change in cognitive performance (representative of cognitive decline) and the rate of change in cognitive performance. We hypothesize that the MRI markers will be more strongly correlated with current CI, whereas serum biomarkers will be more strongly correlated with future and a faster rate of cognitive decline. The findings of this study will have crucial implications for knowing the strengths and limitations of each predictor variable, so that future studies could use this to design effective combinatorial strategies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sahoo, Saswat
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~